New drug tested for stubborn sinus and breathing condition
Disease control
Not yet recruiting
This early-stage study aims to test the safety and effects of an investigational drug called BBT002. It will involve 64 healthy volunteers and people with chronic sinus inflammation with nasal polyps who also have asthma. Researchers will give participants either the drug or a pl…
Phase: PHASE1, PHASE2 • Sponsor: Bambusa Therapeutics • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC